Le Lézard
Classified in: Tourism and vacations, Science and technology, Business
Subjects: PDT, LIC

Quigioco.it Joins Forces with Kensho Media to Elevate Brand Presence and Enhance Online Gaming Services


The latest online brand belonging to the NOVOMATIC Italia Group joins the Kensho network to enhance its brand awareness and the services offered.

HOLBORN, United Kingdom, March 13, 2024 /PRNewswire/ -- The latest online brand belonging to the NOVOMATIC Italia Group joins the Kensho network to enhance its brand awareness and the services offered.

Quigioco.it, part of the HBG Online Gaming group , has embarked on a new partnership with Kensho Media which, through the website Giochidislots.com, will contribute to further increasing the brand awareness of one of the historic Italian gaming and online betting brands, which became part of the NOVOMATIC Group in 2022.

This new collaboration represents a virtuous example of synergy aimed at enriching the gaming experience, ensuring safety and assistance to customers, so that the gaming experience of each user is always characterized by innovation and responsible entertainment.

"We choose our partners paying maximum attention to the themes of safety and responsibility, aspects on which QuiGioco.it focuses and that have impressed us very positively. The platform guarantees a regulated environment, and the registration process is designed to be simple and fast, maintaining high standards of security and compliance," comments Natalia Chiaravalloti, head writer of Giochidislots.com.

Lorenzo Scarpino, Online Products, Digital Content & Operations Lead at Quigioco.it, expresses his satisfaction with the partnership with Kensho which, as he states, "will allow enthusiasts to have at their fingertips, by visiting Giochidislots.com, the portfolio of gaming products of our platform and the wide variety of services that we offer to our customers, including live casinos and virtual games."

Contact:
Kensho Media LTD
***@kenshomedia.com

Photo(s):
https://www.prlog.org/13011521

Press release distributed by PRLog

SOURCE Kensho Media LTD


These press releases may also interest you

at 08:20
Merck and Orion Announce Mutual Exercise of Option Providing Merck Global Exclusive Rights to Opevesostat, an Investigational CYP11A1 Inhibitor, for the Treatment of Metastatic Castration-Resistant Prostate Cancer
Merck , known as MSD outside of the United States and Canada, and Orion Corporation ("Orion") today announced that notice has been provided of the mutual exercise of an option to convert the companies' ongoing co-development and co-commercialization...

at 08:20
Geneoscopy Files Counterclaims Against Exact Sciences
Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of gastrointestinal health, filed a lawsuit asserting multiple claims for damages against Exact Sciences on June 28, 2024, in federal court in the...

at 08:17
Boohoo Doubles Down on Social Commerce with Thousands of Creator Storefronts
After rocketing to success across social media, boohoo announced The boohoo Collective; an initiative redefining social commerce by integrating 1000s of creators into the shopping experience on boohoo.com. The initiative gives any creator a personal...

at 08:15
Masimo Nominee Christopher Chavez Would Bring Fierce Independence, Exemplary Medtech CEO Experience to Masimo Board
Masimo Corporation ("Masimo" or the "Company") today issued a letter to stockholders in connection with the Company's 2024 Annual Meeting of Stockholders. The letter highlights the fierce independence and deep medtech experience of nominee...

at 08:15
Nicholas Cumins Takes Charge as CEO of Bentley Systems, Ushering in a New Era
Following the CEO transition plan previously announced by Bentley Systems, Incorporated , Nicholas Cumins today takes charge as CEO. Cumins succeeds Greg Bentley, the eldest of the five brothers who founded Bentley Systems, who becomes Executive...

at 08:15
KaliVir Immunotherapeutics Announces FDA Clearance of Investigational New Drug (IND) for Oncolytic Immunotherapy VET3-TGI for Solid Tumors
KaliVir Immunotherapeutics, Inc., a biotech company developing cutting-edge, multi-mechanistic oncolytic viral immunotherapy programs, today announced that the FDA has cleared the Investigational New Drug (IND) application for the STEALTH-001 study...

More news about Science and technology...


News published on and distributed by: